Briacell Therapeutics Corp. T.BCT

Alternate Symbol(s): BCTX | BCTXW

Healthcare Biotechnology

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops immunotherapies to transform cancer care. The Company’s lead drug candidate, Bria-IMT, is a cell-based patented immunotherapy that stimulates a patient’s own cancer fighting cells to attack and destroy breast cancer tumors. The Company is advancing its targeted immunotherapy program by prioritizing a Phase II clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor. The Company is focused on conducting a Phase I/IIa clinical trial of Bria-IMT in a combination study with Incyte’s immune PD-1 inhibitor, retifanlimab, in advanced breast cancer. The Company is also developing Bria-OTS, an off-the-shelf personalized approach to whole cell cancer immunotherapy. The Bria-OTS immunotherapy is based on a patient’s HLA-type. Its pipeline also includes Bria-Pros, Bria-Lung, Bria-Mel and sCD80, which are in development to treat various cancers.

TSX:BCT - Post by User

Briacell Therapeutics Corp. > BCTX Fast Track FDA Approval

<< Previous

Bullboard Posts

Next >>

Comment by HomerAndCompanyon Apr 14, 2022 8:42am

135 Views

Post# 34603123

RE:BCTX Fast Track FDA Approval

Sell off on great news after a run-up on no news!? What's going on? -TIA

LondonInvest wrote:
Well this week's options trading isn't at all suspicious! I am long so happy about great advancement for company on outstanding news, but someone definitely leaked something for all those options trades with 2 days left on contract. They make sense now.

https://finance.yahoo.com/news/briacell-receives-fda-fast-track-120000512.html